Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease
Why the study?
Does cardiovascular magnetic resonance imaging improve the detection of myocardial fibrosis and risk stratification compared to conventional measures in patients with severe left-sided valvular heart disease?
Population
Patients with severe left-sided valvular heart disease
Comparison
Cardiovascular magnetic resonance imaging… vs Conventional measures
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports using CMR for preoperative risk stratification in severe valvular heart disease; leaves open whether.
Structured PICO
Does cardiovascular magnetic resonance imaging improve the detection of myocardial fibrosis and risk stratification compared to conventional measures in patients with severe left-sided valvular heart disease?
P
Population
Patients with severe left-sided valvular heart disease (aortic stenosis, aortic regurgitation, and mitral regurgitation)
I
Intervention
Cardiovascular magnetic resonance (CMR) imaging techniques (T1 mapping, late gadolinium enhancement, myocardial tagging, and feature tracking)
C
Comparator
Conventional measures (LV ejection fraction or LV dimensions)
O
Outcome
Detection of myocardial fibrosis and risk stratificationsurrogate
CMR provides a sensitive method for detecting myocardial fibrosis in severe left-sided valvular heart disease, which may aid in risk stratification and predicting post-surgical outcomes.
Cite This Study
Podlesnikar et al. (2017) studied this question.